Basic aggregation properties of washed rat platelets: Correlation between aggregation, phospholipid degradation, malondialdehyde, and thromboxane formation

Basic aggregation properties of washed rat platelets: Correlation between aggregation, phospholipid degradation, malondialdehyde, and thromboxane formation

Basic Aggregation Properties of Washed Rat Platelets: Correlation between Aggregation, Phospholipid Degradation, Mafondialdehyde, and Thromboxane Form...

786KB Sizes 0 Downloads 67 Views

Basic Aggregation Properties of Washed Rat Platelets: Correlation between Aggregation, Phospholipid Degradation, Mafondialdehyde, and Thromboxane Formation

TAKAKO TOMITA, KEIZO UMEGAKI, AND EIICHI HAYASHI

The basic characteristics of washed rat platelets in aggregation and biochemical responses to thrombin and collagen were investigated. Maximum aggregation response to thrombin and collagen was observed in the presence of l-3 mM extracellular CA’+. Breakdown of endogenous phospholipids was followed by HPTLC. Phosphatidylinositol degraded most rapidly and greatly, followed by ph~sphatidyiethanolamine, and phosphatidylchoiine. Sphingomyelin did not change on stimulation. Formation of malondialdehyde was closely associated with thrombin- and collagen-induced aggregation within the range of the concentration employed. In addition, it was correlated with TXBz formation and phosphatidylinositol degradation. These results indicated that, despite known species variation, thrombin-induced aggregation is mediated by TXA2 and malondialdehyde formation reflects both cycle-oxygenase and thromboxane synthaseactivities, and phospholipid degradation in rat platelets as well as in human platelets.

Key Words:

Platelet aggregation; Washed rat platelets; Malondialdehyde; pholipid degradation; Thromboxane

Phos-

INTRODUCTION Considerable information is available about platelet aggregation and the accompanying biochemical events. The information pertaining to platelet aggregation, however, has been gained mostly from human platelets, and such information is lacking for other species of animals, particularly for widely used laboratory animals such as the rat. The rat is a very useful animal species for studying the changes of platelet function due to various pathological conditions and also drug treatment. It has been pointed out that there are great differences in platelet morphology and function in species. Platelet size, circulating numbers, and volume vary enormously between species Won Behrens, 1972). The platelet size is smaller, and the circulating platelet counts (8-12 x 108/ml) are higher in the rat than in humans (1.54.0 x lOa/mI). Rat platelets behave differently, in general, with aggregating agents and aggregation-inhibiting agents. Adrenalin, a proaggregator in human platelets, is inhibitor to thrombin-induced aggregation in the rat (Vu and Latour, 1977). AdenFrom the Department of Pharmacology, Shizuoka College of Pharmaceutical Sciences, Shizuoka, Japan Address requests for reprints to: Takako Tomita, Department of Pharmacology, Shizuoka College of Pharmaceutical Sciences, Ohika, Shizuoka, Japan 422. Received January 25,1983; revised and accepted April l&1983.

31 Journal of Pharmacological Q, 1983 Elsevier

Science

Methods Publishing

IO, 31-44 Co.,

Inc.,

(1983) 52 Vanderbilt

Avenue,

New

York,

NY 10017

32

T. Tomita et al.

osine (Philp, 1970), PGD, (Hayaishi et al., 1982) and dipryidamole (Philp, 1970), known inhibitors of aggretation, do not exert inhibition on the rat platelet aggregation. Dipyridamole is reported to potentiate rat platelet aggregation. The mechanism of platelet aggregation has been extensively studied and a large body of evidence now indicates that TXA, plays a central role in platelet aggregation. Thromboxane synthetase catalyzes the concomitant isomerization and dismutation of PGHp to give TXA2, MDA, and HHT (12-L-hydroxyheptadecatrienoic acid). Thus platelet MDA can be regarded as an indicator of the activities of both cyclo-oxygenase and thromboxane synthetase, and of the release of arachidionic acid from platelet membrane phospholipids (Smith et al., 1976). In the case of rat platelets, however, there is some evidence that questions the role of TXA2 in aggregation. Hwang (1980) reported that preincubation of rat platelet-rich plasma with imidazole, a known inhibitor of thromboxane synthetase, did not attenuate the aggretation induced by ADP or collagen, whereas the synthesis of TXB, was inhibited by more than 90%. In human platelets, imidazole was shown to inhibit thromboxane synthesis and accompanying aggregation induced by PGH, in human platelet rich plasma (Fitzpatrick and Gorman, 1977). Dutilh (Dutilh et al., 1979) demonstrated that prostaglandin endoperoxide, which was rapidly converted into thromboxane AZ, did not cause aggregation in rat platelets, and also that collagen-induced aggregation of rat platelets was completely inhibited by eicosatetrayenoic acid at the concentration at which lipoxygenase activity was completely blocked with an apparent stimulation of cyclooxygenase. Therefore, this study was designed to investigate the basic aggregation characteristics of washed rat platelets, and particularly to assess the significance of MDA assay in aggregation reaction. METHODS Preparation

of Washed

Platelets

Washed platelets were prepared principally according to Baenziger and Majerus (1974). Blood was collected into a siliconized centrifuging tube containing one portion of acid-citrate-dextrose anticoagulant (0.085 M trisodium citrate, 0.065 M citric acid, 2% dextrose) to five portions of blood, and the mixture was consecutively centrifuged for 15 min at 230 x g (1200 rpm) and for 3 min at 800 x g (220 rpm) at room temperature. This two-step centrifugation was employed to prevent a loss of platelets of larger sizes. PRP (platelet-rich plasma) separated from the two centrifugations were mixed, and centrifuged for 7 min at 120 x g (800 rpm) to sediment red and white cells. The supernatant was then centrifuged for 15 min at 1700 x g (3200 rpm). The sedimented platelets were resuspended in the same volume of a washing buffer (0.113 M NaCI, 4.3 mM K2HP04, 4.3 mM Na2HP04, 24.4 mM NaH2P04, 5.5 mM glucose, 1 mM EDTA, pH 6.5) as the whole blood and centrifuged for 15 min, at 1500 x g (3000 rpm) at 4°C. The washed platelets were resuspended in a resuspending buffer (0.14 M NaCI, 15 mM Tris-HCI, 5 mM glucose, pH 7.4) to make a suspension

of about 4 x IO8 cells/ml.

The washed

platelet

suspensions

were

kept at 4°C until used, within 4 hr. The intactness of platelets was ensured throughout all the preparatory stages by measuring the released of lactic acid dehydrogenase activity in the supernatant.

Aggregation Properties of Washed Rat Platelets Measurement

of Platelet Aggregation

The degree of platelet aggregation was measured by the turbidometric method using 4 channeled NKK Hematracer 1 (Niko Bioscience, Tokyo). To 200 ~1 of platelet suspension (adjusted to contain about 4 x IO8 cells/ml), IO ~1 of CaCI, was added to give a final concentration indicated in the legends. 20 ~1 of various concentrations of thrombin or collagen were added after 1 min incubation at 37°C with constant stirring at 1000 rpm, and changes in turbidity were recorded. A maximum aggregation was measured 3 min and 5 min after the addition of thrombin and collagen, respectively. Human plasma thrombin (Midori Cross Co., Osaka, Japan) was diluted with the resuspending buffer. The solution of collagen (Type I, insoluble, Sigma, St. Louis, MO) was prepared according to lnoshita et al. (1976), and collagen in the solution was determined by the method of ltzhaki et al. (1964). Incubation

of Platelets

A suspension of washed rat platelets (4 x IO8 cells/ml) was incubated either with collagen or with thrombin at 37°C in the presence of 1.5 mM Ca’+. Incubation conditions are described in detail in the legend for each figure. Extraction of Platelet Phospholipids To 0.5 ml of platelet suspension, 2.2 ml of a mixture of CHC&: MeOH (1 : 2) was added to stop the incubation. The mixture was shaken vigorously for 1 min with 0.71 ml of CHC& and 0.71 ml of 2 M KCI solution containing 5 mM EDTA, and centrifuged for 30 min at 3000 rpm. The lower layer was withdrawn and the solvent was removed under a vacuum. Analysis of Platelet Phospholipids The phospholipid extract was dissolved in 50 ~1 of a mixture of CHC& : MeOH : HZ0 (75 : 25 : 2), and a portion of the extract was applied on a HPTLC plate (Kieselgel 60, art No. 5641, 10 x 20 cm, Merch, Darmstadt, Germany.), which was rinsed with a mixture of CHC13 : MeOH (2 : 1) overnight and activated by heating for 1 hr at 110°C. The plate was developed at 4°C in a mixture of CHC&: MeOH: CH3NH2 (40%) (63 : 35 : 10). After the solvents were completely removed under a hot air stream, the plate was heated for 10 hr at 150°C with ammonium bicarbonate in a sealed chamber to develop fluorescence (Kupke, 1978). The intensity of fluorescence in each phospholipids was measured by a CAMAG TLC Scanner (Muttenz, Swiss). Analysis of MDA To 0.25 ml of platelet suspension, 0.1 ml of 3.1 M trichloroacetic acid (final concentration, 0.8 M) was added to stop the incubation. Malondialdehyde formed by platelet reaction was measured principally according to Ohkawa et al. (1978). A portion of the mixture (0.4 ml) was mixed with 0.4 ml of 3% sodium dodecylsulfate (Wako Chemicals, Tokyo), and then heated at 70°C for 45 min with 1.6 ml of 0.1 N HCI, 0.8 ml of 10% phosphotungstic acid, and 0.8 ml of 0.7% thiobarbituric acid (Nakarai Chemicals, Tokyo). The reaction was terminated by chilling, and the flu-

33

34

T. Tomita et al.

orescent products were extracted with 4 ml of n-butanol. The intensity of fluorescence was measured as percent fluorescence of Rhodamin B (20 ng/ml) by a Hitachi fluorescence Photmeter (Hitachi 204, Hitachi Co. LTD, Tokyo) (excitation 515 nm, emission 553 nm). For a calibration curve, 50-860 p mol of 1, 1, 3, 3-tetraethoxypropane (a gift from Eizai Pharmaceuticals, Tokyo, Japan) in 0.4 ml of 0.8 M trichloroacetic acid, was submitted to the reaction as described above, and the fluorescence was measured. Radioimmunoassay

of TXB2

To 0.5 ml of platelet suspension, 2 M citric acid was added to adjust pH to 3.0 and to stop the reaction. The mixture was chilled in liquid nitrogen and kept at -80°C till assayed. The thawed samples were neutralized with 1 M NaOH, and thromboxane B2 in the diluted samples was assayed by using thromboxane B, t3Hl RIA Kit (NEN, Boston, MA).

RESULTS Aggregation

Response

in Rat-Washed

Platelets

Figure 1 shows typical aggregation response to thrombin and collagen in washed platelets from Wistar Kyoto rats in the presence of 1.5 mM Ca*‘. Aggregation reached a maximum at 3 min with thrombin and at 5 min with collagen. As Figure 2A shows, aggregation was dose-dependent in the range of 0.1-0.3 U of thrombin/ml

83.7 )rg/ml 0.44 U/ml

16.7 pg/ml 0.17 U/ml 8.4 pg/ml

20

0.13 U/ml

tr 0-

12

3

'123456

4 Time

(

min

)

FIGURE 1. Typical aggregation response to three concentrations of a) thrombin and b) collagen in washed rat (Wistar Kyoto) platelets in the presence of 1.5 mM Ca2+.

100.

35 _-_--A ___--/___-----;--

80'

l

/-&---

"

/

/'/'

60 .

/

,' E .c +I z?

i

:

;40. 4"

:'

I a

f

0'

0.1

0.2

0

50

100

0.3 150

0.4

Thranbin

U/ml

200

Collagen

pg/ml

FIGURE 2A. Platelet aggregation induced by various concentrations of thrombin (-•-_) and collagen (-A-). Washed rat (WKY) platelets were stimulated either with thrombin (0.087, 0.11, 0.13, 0.15, 0.17, 0.22, 0.26, and 0.44 U/ml) or with collagen (6.2, 7.5, 9.3, 12.5, 18.7, 46.7, 93.4, and 187 pg/ml) in the presence of 1.5 mM Ca*+.

FIGURE 2B. Effects of Ca*’ concentration on platelet aggregation. Washed rat (WKY) platelets were stimulated either with thrombin (0.22 U/ml) in the presence of Ca’+ (0.125, 0.25, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 6.0, 8.0, 10.0, and 20.0 mM) or with collagen (lo.7 pg/ml) in the presence of Ca2+ (0.5, 1.0, 2.0, 9.0, and 23.0 mM). Each point represents mean for triplicates.

343 T. Tomita et al. and IO-100 pg collagen/ml. The thrombin concentration at which 50% aggregation was induced varies even within strains of rats. It was between 0.15-0.2 U/ml in Wistar Kyoto rats, but between 0.6-0.7 U/ml in Wistar Mishima. lndomethacin (42 pgiml) inhibited thrombin (0.42 U/ml)-induced aggregation by 69% in the presence of 1.5 mM Ca*‘. Fig 2 B shows the strong dependency of rat platelet aggregation on Ca” concentration. Thrombin (0.22 U/ml) or collagen (10.7 F./ml) scarcely induced aggregation with washed rat platelets in the absence of Ca2+. The presence of l-3 mM Ca*‘, however, induced a maximum aggregation response to thrombin and collagen, while at the higher concentration aggregation was inversely reduced with the concentration. Thrombin-induced aggregation was completely inhibited at 20 mM of Ca*‘. The cell density of rat platelet preparations did not affect the aggregability within the range of 2-6 x IO’ cells/ml (Figure 3). Analysis of Platelet Phospholipids Phospholipids extracted from platelets before and after stimulation with thrombin were separated by HPTLC and fluorescence was developed by heating the plate with ammoniumbicarbonate for IO hr at 150°C. Figure 4 shows the profile of rat platelet phospholipids. A linear correlation was observed between the intensity of fluorescence developed on each phospholipid and the concentration of phospholipids (Figure 5). Contents of PC, PE, and PI in washed rat platelets (unstimulated) 100

I

-0 .------_-__-______ A

0

1 2.0 Cell density

4.0

( x l@

6.0 Cells

8.0 / ml

)

FIGURE 3. The dependency of aggregation on the cell density of rat platelet suspension. Washed rat (WKY) platelets were stimulated with thrombin (-•-) (0.44 U/ml) and with collagen (---A---) (46.7 @ml) in the presence of 1.5 mM Ca*+.

Control

(thrombln

Stimulated 12.5

U/ml,

3 min

)

PE

PC SM

PI

i

FIGURE 4. A profile of rat platelet phospholipids before and after stimulation with thrombin (12.5 U/ml) for 3 min. Platelet phospholipids were extracted by CHCI,: methanol (1 :2), and separated by HPTLC using CHC&: menthanol:methylamine (63:35: 10) as a developing solvent. Intensity of fluorescence in each phospholipid was measured by CAMAG HPTLC scanner. PE

0

/ 0

PI

PC

1

0

0.5

1 .o

1.5

2.0

( p9

I

0

0.5

1.0

1.5

2.0

PE ( pg

)

0

1 .o

2.0

3.0

4.0

PC ( p3

1

FIGURE 5. Standard curves of phospholipids. determination.

PI

Each point represents the mean of triplicate

38

-----______ --------______ -----*

SM

m PC .\A

PE

l

-o--------.

0‘

2.0

4.0

PI

8.0

6.0

Thrombin

10.0 (

U 1 ml

12.0

14.0

16.0

)

FIGURE 6A. Effects of thrombin concentration on phospholipid degradation in platelets. Washed rat platelets were incubated at 37°C for 3 min with thrombin (0.88, 2.63, 4.39, 7.02, 8.77, and 17.5 U/ml) in the presence of 3.5 mM Ca*+. Each point represents the mean of duplicates.

01

1

2 3 Incubation time ( min )

lncubaffo”

time

( min

1

o-

Incubation time ( min

,

Incubation time ( min )

FIGURE 6B. Time course of changes in platelet phospholipid composition following thrombin stimulation. Washed rat platelets were incubated for 5, 30 set, 1, 2, and 3 min at 37°C with thrombin (0.88 U/ml) in the presence of 2.9 mM Ca”. Each points represents the mean and S. E. of triplicates.

0

10

*Clca*+( liw

)

FIGURE 7A. The effect of Ca2* on the formation of malandialdehyde in rat platelets stimulated either with thrombin (-O--)(1.78 U/ml) for 3 min in the presence of 0.54,f.09,2.17, 4.35 10.3, and 20 .0 mM Ca2* I or with collagen f---A---) f25.0 t.kgfml) for 5 min in the presence of Ok~4~1.09, 2.17, $35, 8.09, 13.4, and 21.7 mM Ca”,

Time after stimulation

( min )

FIGURE 7&. Time course of the formation of mafondialdehyde in rat platekts &mutation either with thtombin (-a--_) (8.8 U/ml) or with collagen (---A---) (100 tt,g/mlI in the presence of25* m&t Caz’ .

r = 0.967

80 -

(A)

60 -

40.

20 *

A

OLb.

0.6

0.4 MDA

01

(p mol/pg

1.0

0.8 protein)

I

L

1.0

2.0

I

3.0

MDA (p mol/ug protein)

Correlation between aggregation and the formation of malondialdehyde in FIGURE 8A,B. rat platelets stimulated A) with thrombin (0.097-0.87 U/ml) for 3 min, and B) with collagen (0, 9.34, 18.7, 46.7, 93.4 and 186 @ml) for 5 min in the presence of 1.5 mM Ca*+.

Aggregation

0'

0.5

Properties of Washed Rat Platelets

1.0

TXB2 ( p mol / pg protein

1.5

2.0

)

FIGURE 8C. Correlation between the formation of thromboxane B2 and malondialdehyde in rat platelets stimulated with thrombin (0, 0.087, 0.11, 0.13, 0.15, 0.17, 0.22, 0.26, 0.44, 0.87, 1.74, and 8.71 U/ml) for 3 min in the presence of 1.5 mM Ca’+.

were 73 t 8.3 (8), 47 t 5.7 (8), and 8.7 IL 0.85 (6) kg/IO’ cells, respectively, measured by this micromethod. Phospholipid

Degradation

by Thrombin

when

Stimulation

The microanalysis of phospholipids described above made it possible to follow the stimulation-induced changes in the small amounts of phospholipids in platelet membranes without previous labeling that may result in unequal distribution of labeled substances in membrane phospholipids. Figure 6A shows percent changes of phospholipids when platelets were stimulated with thrombin at various concentrations. The degradation of PI reached a maximum at 7 U of thrombin/mI, while that of PC and PE reached a plateau at 3 U of thrombin/ml. The rate of degradation was greatest in Pi, followed by PE and PC, while the amount of sphingomyelin was unchanged by thrombin-stimulation. Figure 6B) shows the time course of phospholipid degradation when platelets were stimulated with 8.8 U of thrombin/ml. Degradation of PI occurred rapidly (21%, 30%, 39%, 44% at 30 set, 1, 2, and 3 min after being stimulated with thrombin). Formation

of MDA

Formation of MDA in platelets following stimulation was absolutely Ca*+-dependent. A maximum formation was observed at l-3 mM Ca2’, and the formation was gradually reduced with increasing concentrations over 3 mM. The Ca*’ dependency

41

42

T. Tomita et al.

(Figure

7A) and the time

with those formation

of platelet induced

Correlation

course

of MDA

aggregation.

by thrombin

between

production

lndomethacin

(0.42 U/ml)

(Figure

7B) were

(42 tJ,g/ml) inhibited

in the presence

consistent

by 76% MDA

of 1.5 mM Ca*+.

Aggregation,

MDA,

and TXBz Formation,

and MDA

formation

were measured

and PI

Degradation Aggregation

response

concomitantly

3 min

after the platelets were stimulated with various amounts of thrombin (0.057-0.87 U/ml) in the presence of 1.5 mM Ca*’ and the result is shown in Figure 8A which demonstrates 88 shows amounts

a strong

a similar of collagen

simultaneous

correlation

result

between aggregation

obtained

(9.34-186

assay of TXB2

when

platelets

and MDA formation.

were

stimulated

Kg/ml) for 5 min in the presence

and MDA

in platelets

stimulated

with

Figure various

of 1.5 mM Ca’+. A

with thrombin

(0.087-

8.71 U/ml) for 3 min in the presence of 1.5 mM Ca*+, shows a good correlation between the formation of the two substances in rat platelets (Figure 80. As shown in Figure

9, MDA

formation

phospholipid which shows dicate that MDA formation genase and thromboxane

also was correlated

with

the degradation

of PI, the

the greatest change after stimulation. These results inreflects phospholipid degradation, and also cyclo-oxysynthetase

activities

in rat platelets.

0.987 40 -

,’

@/ l

o

0

H .z 30 . z 2 0P =

20 .

r

lo: 0

l

l

/

.

/ 100

200

MDA ( p mol / pg protein

300

)

FIGURE 9. Correlation between malondialdehyde formation and the degradation of phosphatodylinositol (percent) in rat platelets stimulated with thrombin in the presence of 2.9 mM Ca’+. Each point represents the mean of triplicate determination.

Aggregation

Properties of Washed Rat Platelets

DISCUSSION Although aggregation response with platelet-rich plasma reflects platelet aggregability, and thus, platelet-rich plasma is widely used, various humoral factors influencing platelet aggregation are present in such preparations. Rat plasma contains four times more TXA2 than human plasma (Hwang et al., 19801, and no prostaglandin D2 (Moncada and Vene, 19781, which is inhibitory to human platelet aggregation. Production of PG12, a potent inhibitor of aggregation, also is found to be much higher in rat aorta than in the rabbit, the porcine, and the bovine (Morita et al., 1983). In addition, the concentration of these factors may fluctuate according to pathological conditions. For these reasons, washed platelets were used in this investigation to study rat platelet function. The presence of extracellular Ca2+ was required for the aggregation in washed rat platelets. The optimum concentration is about l-3 mM and concentrations greater than 3 mM reduced aggregation. Malondialdehyde formation was proposed by Smith et al. (1976) as an indicator of cycle-oxygenase and thromboxane synthetase activities and also the release of arachidonate in human platelets. Since there exists wide species variation in platelet responses to proaggregators and inhibitors (Dodds, 1978), and also in the role of TXA2 in aggregation, a simultaneous study of aggregation, MDA, and TXB, formation, and phospholipid degradation was undertaken in washed rat platelets. At the concentrations of thrombin and collagen indicated in the legends of the figures, a good correlation between aggregation and formation of MDA was observed. Furthermore, MDA formation was well correlated with TXB2 formation and PI degradation. Thrombin-induced aggregation and MDA formation were inhibited by indomethacin. These results strongly indicate that TXA, is an important endogenous proaggregator, and MDA formation reflects cycle-oxygenase and thromboxane synthetase activities, and phospholipid degradation in rat platelets as well as in human platelets. The authors are grateful to MS C. Nanjo for her technical assistance and to MS Y. Serizawa for typing the manuscript.

REFERENCES Baenziger NL, Majerus PW (1974) Isolation of human platelets and platelet surface membranes. Methods Enzyme/31:149-155. Dodds WJ (1978) Platelet function in animals: species specificities. In: Platelets: A Multidisciplinary Approach. Eds., C De Gaetano and S Garattini. New York: Raven Press, pp. 45-59. Dutilh CE, Haddeman E, Jouvenaz GH, Ten Hoor F, Nugteren DH (1979) Study of the two pathways for arachidonate oxygenation in blood platelets. Lipids 14:241-246.

Fitzpatrick F, Gorman RR (1977) Platelet rich plasma transforms exogenous prostaglandin endoperoxide Hz into thromboxane AZ. Prostaglandins 14:881-889.

Hayaishi 0, Watanabe T, Yamashita A, Ogorochi T, Narumiya S, Shimizu T (1982) Antithrombotic action of prostaglandins: Different roles of postacyclin and PGDZ. Adv Pharmacol Therap II 4:251260.

Hwang DH (1980) Aggregation and inhibition of rat platelets and the formation of endoperoxide me-

43

44

T. Tomita et al. tabolites.

Prostaglandms

and

Medicine

5:163-

Hwang

DH,

variation their

Codke

RA,

in serum

precursor

lnoshita

K, lmaoka

K, Kosaki

Rings

levels

RW

(1980)

of prostaglandins

test.

Blood

suspension & Vessel

proteins.

IR, Zeugner

formance plasma plication

of 0.5 ~1 samples

I Chromatogr

after

tidisciplinary S Garattini. Morita fects

for

high-perin

direct

ap-

to the silica-gel

Eds.,

Approach.

I, Takahashi

In:

layer.

A Mu/-

G De Gaetano and

R, Saito Y, Murota

of eicosapentaenoic

platelet ag-

Platelets:

Raven Press,

H, Ohishi

pp. 239-258. S (1983) Ef-

acid on arachidonic

cells

Thromb

and

Res,

in

Philp

RB

Anal.

Biochem

(1970)

JB, lngerman

landin production Med

Behrens

WE

Silver

the

MJ (1976)

as an indicator

rat.

Malon-

of prostag-

by human platelets.

Latour

hibition

(1972) Evidence

of the circulating

man. Thromb

Diath

Haemorrh

JG (1977)

by B-adrenergic

let aggregation. and

in

23:129-139.

/. Lab C/in

881167-172.

canalisation Yu SK,

CM,

formation

of

and dipyri-

potentiation

Haemorrh

acid

inhibition

by adenosine

Paradoxical Diath

dialdehyde

by thiobarbituric 95:351-358.

Species-dependent

aggregation

damole: Smith

N, Yagi K (1978) Assay for lipid

in animal tissues

reaction.

Von

and thrombosis. New York:

Ohkawa

Thromb

of lipids

vascular

difference.

press.

platelet

146:261-271.

Moncada S, Vane JR (1978) Prostacyclin, gregation,

method

chromatography homogenates

for plate-

9:401-410.

S (1978) Quantitative

thin-layer

and liver

Anal Biochem

H, lshi

7:719-726.

RF, Gill DM (1964) A micro-biuret

Kupke

and

in cultured

Species

peroxides

S, Ogawa M, Sasakuma

G (1976) Collagen

estimating

Species

acids. Lipids 15:597-600.

let aggregation ltzaki

acid metabolism platelets.

173.

rabbit

371413-422.

mass

in

27:159-172.

Potentiation stimulations

A comparative platelets.

of phylogenetic platelet

by cy and inof rat plate-

study with human

Thrombos

Haemostas